Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection
- PMID: 8806568
- DOI: 10.1006/viro.1996.0484
Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection
Abstract
Type III nitric oxide synthase (type III NOS), also known as endothelial cell nitric oxide synthase (eNOS or ecNOS or NOS-3), is a constitutively expressed, calcium- and calmodulin-dependent, isoform of NOS. Its expression has been localized to endothelial cells and a subset of neurons in the brain. We report here that resident astrocytes of the central nervous system (CNS) of mice express type III NOS. Following an experimental neurotropic viral infection, the expression of type III NOS on reactive astrocytes increases substantially, predominantly in virally infected regions of the brain. This upregulation of type III NOS expression is also evident following cytokine treatment in vitro. The intraperitoneal (i.p.) administration of IL-12, a potent activator of IFN-gamma and TNF-alpha production, results in a substantial increase in type III NOS immunoreactivity in astrocytes. Cytokine-mediated activation of type III NOS is observed in vitro following exposure of a C6 glioma cells, which constitutively express type III NOS, to IL-12, IFN-gamma, and TNF-alpha treatment. We conclude that astrocytes of the murine CNS express type III NOS, which may be positively regulated by a number of cytokines following viral infection. Type III NOS expression by astrocytes represents a novel source of nitric oxide in the brain. It may be important in regulating perfusion and maintaining the blood-brain barrier. Given the intimate association of astrocytes with endothelial cells and neurons, increased activity of type III NOS following viral infection may be beneficial in inhibition of viral infection in neighboring cells.
Similar articles
-
IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb.J Immunol. 1997 Oct 1;159(7):3444-52. J Immunol. 1997. PMID: 9317143
-
Neuronal expression of NOS-1 is required for host recovery from viral encephalitis.Virology. 1999 Jun 5;258(2):389-95. doi: 10.1006/viro.1999.9734. Virology. 1999. PMID: 10366576
-
Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist.J Immunol. 1996 Oct 15;157(8):3569-76. J Immunol. 1996. PMID: 8871657
-
Nitric oxide synthase isozymes antibodies.Histochem J. 1995 Oct;27(10):738-44. Histochem J. 1995. PMID: 8575937 Review.
-
The role of IFN-gamma in immune responses to viral infections of the central nervous system.Cytokine Growth Factor Rev. 2002 Dec;13(6):441-54. doi: 10.1016/s1359-6101(02)00044-8. Cytokine Growth Factor Rev. 2002. PMID: 12401479 Review.
Cited by
-
Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice.J Exp Med. 1998 Oct 19;188(8):1541-6. doi: 10.1084/jem.188.8.1541. J Exp Med. 1998. PMID: 9782132 Free PMC article.
-
Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury.Exp Neurol. 2005 Oct;195(2):379-90. doi: 10.1016/j.expneurol.2005.05.016. Exp Neurol. 2005. PMID: 16004984 Free PMC article.
-
IL-12 and viral infections.Cytokine Growth Factor Rev. 1998 Sep-Dec;9(3-4):277-85. doi: 10.1016/s1359-6101(98)00017-3. Cytokine Growth Factor Rev. 1998. PMID: 9918125 Free PMC article. Review.
-
Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice.Infect Immun. 2004 Jul;72(7):4081-9. doi: 10.1128/IAI.72.7.4081-4089.2004. Infect Immun. 2004. PMID: 15213153 Free PMC article.
-
DISTINCT MECHANISMS OF INHIBITION OF VSV REPLICATION IN NEURONS MEDIATED BY TYPE I AND TYPE II IFN.Virus Rev Res. 2009 Jan 1;14(2):20-29. Virus Rev Res. 2009. PMID: 20502625 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
